Utility of FET-PET in detecting high-grade gliomas presenting with equivocal MR imaging features

被引:9
|
作者
Puranik, Ameya D. [1 ]
Boon, Mathew [1 ]
Purandare, Nilendu [1 ]
Rangarajan, Venkatesh [1 ]
Gupta, Tejpal [2 ]
Moiyadi, Aliasgar [3 ]
Shetty, Prakash [3 ]
Sridhar, Epari [4 ]
Agrawal, Archi [1 ]
Dev, Indraja [1 ]
Shah, Sneha [1 ]
机构
[1] Homi Bhabha Natl Univ, Tata Mem Hosp, Dept Nucl Med & Mol Imaging, Mumbai, Maharashtra, India
[2] Homi Bhabha Natl Univ, Tata Mem Hosp, Dept Radiat Oncol, Mumbai, Maharashtra, India
[3] Homi Bhabha Natl Univ, Tata Mem Hosp, Dept Neurosurg, Mumbai, Maharashtra, India
[4] Homi Bhabha Natl Univ, Tata Mem Hosp, Dept Pathol, Mumbai, Maharashtra, India
关键词
Brain lesions; fluoroethyl-tyrosine-positron-emission tomography; high-grage glioma; magnetic resonance imaging; POSITRON-EMISSION-TOMOGRAPHY; NERVOUS-SYSTEM LYMPHOMA; F-18-FET PET; UPTAKE KINETICS; BRAIN-TUMORS; DIFFERENTIATION; PERFORMANCE; METASTASES; TRANSPORT;
D O I
10.4103/wjnm.WJNM_89_18
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
High-grade gliomas, metastases, and primary central nervous system lymphoma (PCNSL) are common high-grade brain lesions, which may have overlapping features on magnetic resonance (MR) imaging. Our objective was to assess the utility of 18-fluoride-fluoro-ethyl-tyrosine positron emission tomography (FET-PET) in reliably differentiating between these lesions, by studying their metabolic characteristics. Patients with high-grade brain lesions suspicious for glioma, with overlapping features for metastases and PCNSL were referred for FET-PET by Neuroradiologists from Multidisciplinary Neuro-Oncology Joint Clinic. Tumor-to-contralateral white mater ratio (T/Wm) at 5 and 20 min was derived and compared to histopathology. Receiver operating characteristic curve analysis was used to find the optimal T/Wm cutoff to differentiate between the tumor types. T/Wm was higher for glial tumors compared to nonglial tumors (metastases, PCNSL, tuberculoma, and anaplastic meningioma). A cutoff of 1.9 was derived to reliably diagnose a tumor of glial origin with a sensitivity and specificity of 93.8% and 91%, respectively. FET-PET can be used to diagnose glial tumors presenting as high-grade brain lesions when MR findings show overlapping features for other common high-grade lesions.
引用
收藏
页码:266 / 272
页数:7
相关论文
共 50 条
  • [41] Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients
    Vees, Hansjoerg
    Senthamizhchelvan, Srinivasan
    Miralbell, Raymond
    Weber, Damien C.
    Ratib, Osman
    Zaidi, Habib
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (02) : 182 - 193
  • [42] Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR
    Behr, Spencer C.
    Villanueva-Meyer, Javier E.
    Li, Yan
    Wang, Yung-Hua
    Wei, Junnian
    Moroz, Anna
    Lee, Julia K. L.
    Hsiao, Jeffrey C.
    Gao, Kenneth T.
    Ma, Wendy
    Cha, Soonmee
    Wilson, David M.
    Seo, Youngho
    Nelson, Sarah J.
    Chang, Susan M.
    Evans, Michael J.
    JCI INSIGHT, 2018, 3 (21):
  • [43] Neurosarcoidosis Mimics High-Grade Glioma in Dynamic 18F-FET PET Due to LAT Expression
    Unterrainer, Marcus
    Diekmann, Caroline
    Dorostkar, Mario
    Vettermann, Franziska Jill
    Kuempfel, Tania
    Tonn, Joerg-Christian
    Bartenstein, Peter
    Albert, Nathalie Lisa
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (11) : 840 - 841
  • [44] Prognostic Significance of Dynamic 18F-FET PET in Newly Diagnosed Astrocytic High-Grade Glioma
    Jansen, Nathalie L.
    Suchorska, Bogdana
    Wenter, Vera
    Schmid-Tannwald, Christine
    Todica, Andrei
    Eigenbrod, Sabina
    Niyazi, Maximilian
    Tonn, Joerg-Christian
    Bartenstein, Peter
    Kreth, Friedrich-Wilhelm
    la Fougere, Christian
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (01) : 9 - 15
  • [45] Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma Patients
    Yoo, Roh-Eul
    Choi, Seung Hong
    MAGNETIC RESONANCE IN MEDICAL SCIENCES, 2016, 15 (02) : 165 - 177
  • [46] The impact of tumor metabolic activity assessed by 18F-FET amino acid PET imaging in particle radiotherapy of high-grade glioma patients
    Waltenberger, Maria
    Furkel, Jennifer
    Roehrich, Manuel
    Salome, Patrick
    Debus, Charlotte
    Tawk, Bouchra
    Gahlawat, Aoife Ward
    Kudak, Andreas
    Dostal, Matthias
    Wirkner, Ute
    Schwager, Christian
    Herold-Mende, Christel
    Combs, Stephanie E.
    Koenig, Laila
    Debus, Juergen
    Haberkorn, Uwe
    Abdollahi, Amir
    Knoll, Maximilian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Prognostic value of 18F-FET PET imaging in re-irradiation of high-grade glioma: Results of a phase I clinical trial
    Moller, Soren
    Law, Ian
    Af Rosenschold, Per Munck
    Costa, Junia
    Poulsen, Hans Skovgaard
    Engelholm, Svend Aage
    Engelholm, Silke
    RADIOTHERAPY AND ONCOLOGY, 2016, 121 (01) : 132 - 137
  • [48] Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis
    Muoio, Barbara
    Albano, Domenico
    Dondi, Francesco
    Bertagna, Francesco
    Garibotto, Valentina
    Kunikowska, Jolanta
    Piccardo, Arnoldo
    Annunziata, Salvatore
    Espeli, Vittoria
    Migliorini, Denis
    Treglia, Giorgio
    DIAGNOSTICS, 2022, 12 (07)
  • [49] Ga-68 PSMA PET/CT in recurrent high-grade gliomas: evaluating PSMA expression in vivo
    Kumar, Arunav
    ArunRaj, Sreedharan Thankarajan
    Bhullar, Khush
    Haresh, K. P.
    Gupta, Subhash
    Ballal, Sanjana
    Yadav, Madhav
    Singh, Manmohan
    Damle, Nishikant Avinash
    Garg, Ajay
    Tripathi, Madhavi
    Bal, Chandrasekhar
    NEURORADIOLOGY, 2022, 64 (05) : 969 - 979
  • [50] Diagnostic Accuracy of PET with 18F-Fluciclovine ([18F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis
    Castello, Angelo
    Albano, Domenico
    Muoio, Barbara
    Castellani, Massimo
    Panareo, Stefano
    Rizzo, Alessio
    Treglia, Giorgio
    Urso, Luca
    DIAGNOSTICS, 2023, 13 (24)